AMRS * logo

Amyris BMV:AMRS * Stock Report

Last Price

Mex$1.00

Market Cap

Mex$645.6k

7D

0%

1Y

-97.1%

Updated

15 Nov, 2023

Data

Company Financials +

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

AMRS * Stock Overview

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. More details

AMRS * fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Amyris, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Amyris
Historical stock prices
Current Share PriceUS$1.00
52 Week HighUS$41.00
52 Week LowUS$1.00
Beta1.28
1 Month Change0%
3 Month Change0%
1 Year Change-97.07%
3 Year Changen/a
5 Year Changen/a
Change since IPO-99.66%

Recent News & Updates

Recent updates

Shareholder Returns

AMRS *MX ChemicalsMX Market
7D0%0.7%1.1%
1Y-97.1%-15.5%-5.2%

Return vs Industry: AMRS * underperformed the MX Chemicals industry which returned -14.8% over the past year.

Return vs Market: AMRS * underperformed the MX Market which returned 3.7% over the past year.

Price Volatility

Is AMRS *'s price volatile compared to industry and market?
AMRS * volatility
AMRS * Average Weekly Movementn/a
Chemicals Industry Average Movement4.6%
Market Average Movement4.8%
10% most volatile stocks in MX Market8.7%
10% least volatile stocks in MX Market2.8%

Stable Share Price: AMRS *'s share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine AMRS *'s volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20031,598Han Kieftenbeldamyris.com

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names.

Amyris, Inc. Fundamentals Summary

How do Amyris's earnings and revenue compare to its market cap?
AMRS * fundamental statistics
Market capMex$645.56k
Earnings (TTM)-Mex$10.66b
Revenue (TTM)Mex$4.65b

0.0x

P/S Ratio

0.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
AMRS * income statement (TTM)
RevenueUS$268.22m
Cost of RevenueUS$369.78m
Gross Profit-US$101.55m
Other ExpensesUS$512.99m
Earnings-US$614.55m

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.65
Gross Margin-37.86%
Net Profit Margin-229.12%
Debt/Equity Ratio-145.2%

How did AMRS * perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/11/15 05:30
End of Day Share Price 2023/08/18 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Amyris, Inc. is covered by 16 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
J. HorwitzBaird
Carter DriscollB. Riley Securities, Inc.
Susan AndersonCanaccord Genuity